Holen Sie sich die Stockscreener-App
1.83
8.93%
0.15
Handel nachbörslich:
1.82
-0.01
-0.55%
Intelligent Bio Solutions Inc Aktie (INBS) Neueste Nachrichten
Intelligent Bio Solutions Launches In-House Fingerprint Drug Testing Across 20+ Sites for Major Australian Waste Operator, Accelerating APAC Expansion - MarketScreener
INBS Expands Reach with Innovative Drug Screening Adoption in Au - GuruFocus
Intelligent Bio Solutions Launches In-House Fingerprint Drug Testing Across 20+ Sites for Major Australian Waste Operator, Accelerating APAC Expansion | INBS Stock News - GuruFocus
Intelligent Bio Solutions Inc. Partners with Managed Waste Service to Implement Innovative Drug Screening Technology in New South Wales Operations - Nasdaq
Revolutionary Fingerprint Drug Test Launches Across 20+ Sites in Major Australian Expansion - Stock Titan
EXCLUSIVE: Intelligent Bio's Fingerprint Drug Testing Gains Momentum With New Australian Rollout - Benzinga
The Future of Drug Testing? Fingerprint Tech From Intelligent Bio Solutions (NASDAQ:INBS) Shows Serious Promise - simplywall.st
Intelligent Bio Solutions (NASDAQ: INBS) CEO Highlights Fingerprint Drug Testing on BioMedWire Podcast - The Globe and Mail
IBN Announces Latest Episode of The BioMedWire Podcast - GlobeNewswire
INBS Stock May Rise on SMARTOX Partnership Expanding Forensic Reach - Yahoo Finance
Reviewing Intelligent Bio Solutions (NASDAQ:INBS) & AngioDynamics (NASDAQ:ANGO) - Defense World
Intelligent Bio Solutions Inc (INBS) Stock: A Comprehensive 52-Week Review - investchronicle.com
Intelligent Bio Solutions Expands U.S. Forensic Market Presence, - GuruFocus
# INBS fingerprint drug screening system deployed in over 50 US locations By Investing.com - Investing.com South Africa
Intelligent Bio Rises On Partnership With Smartox To Expand US Market Presence: Retail Hopes The Stock To Hit $2.6 - MSN
EXCLUSIVE: Intelligent Bio Solutions Expands US Forensic Market Presence, Seeks FDA Clearance For Fingerprint Drug Testing - AOL.com
INBS Expands U.S. Forensic Market Reach Through SMARTOX Partners - GuruFocus
# INBS fingerprint drug screening system deployed in over 50 US locations - Investing.com Nigeria
INBS Expands U.S. Forensic Market Reach Through SMARTOX Partnership | INBS Stock News - GuruFocus
Intelligent Bio Solutions Expands U.S. Forensic Market Presence, Seeks FDA Clearance for Breakthrough Fingerprint Drug Testing | INBS Stock News - GuruFocus
Intelligent Bio Solutions Expands U.S. Forensic Market Presence, Seeks FDA Clearance for Breakthrough Fingerprint Drug Testing - The Manila Times
Fingerprint Drug Test Breakthrough: 7,000 Tests Completed as FDA Clearance Nears | INBS Stock News - Stock Titan
IBN Coverage: Intelligent Bio Solutions (NASDAQ: INBS) Showcases Portable Drug Testing System at RISE25 - Yahoo Finance
Intelligent Bio Solutions (NASDAQ: INBS) Showcases Portable Drug Testing System at RISE25 - The Globe and Mail
iAccess Alpha's Virtual Best Ideas Spring Investment Conference March 25-26, 2025 - The Globe and Mail
Intelligent Bio Solutions (NASDAQ: INBS) Progressing with FDA Clearance for Fingerprint Drug Testing as Global Demand Grows - TipRanks
IBN Coverage: Intelligent Bio Solutions (NASDAQ: INBS) Progressing with FDA Clearance for Fingerprint Drug Testing as Global Demand Grows - Yahoo Finance
Healthcare's Quiet AI Boom Is Creating a New Class of Breakout Contenders - The Globe and Mail
Intelligent Bio Solutions Advances Innovative Fingerprint Drug Testing Technology Toward U.S. Market - citybuzz -
Intelligent Bio Solutions (NASDAQ: INBS) to Showcase Fingerprint Drug Testing at RISE25 Conference - TipRanks
IBN Coverage: Intelligent Bio Solutions (NASDAQ: INBS) to Showcase Fingerprint Drug Testing at RISE25 Conference - Yahoo Finance
Intelligent Bio Solutions to Showcase Fingerprint Drug Testing a - GuruFocus
Intelligent Bio Solutions (INBS) to Showcase Drug Testing System at RISE25 | INBS Stock News - GuruFocus
Intelligent Bio Solutions to Showcase Fingerprint Drug Testing at RISE25 Conference from May 28-31, Supporting Innovation in U.S. Forensic Drug Testing - The Manila Times
Intelligent Bio Solutions to Showcase Fingerprint Drug Testing at RISE25 Conference from May 28-31, Supporting Innovation in U.S. Forensic Drug Testing | INBS Stock News - GuruFocus
Intelligent Bio Solutions Inc. to Showcase Drug Testing Innovation at RISE25 Conference with Partner SMARTOX - Nasdaq
Revolutionary 10-Minute Fingerprint Drug Test Targets US Forensic Market at RISE25 Conference - Stock Titan
NYSE Content Advisory: Pre-Market update + Retailers report earnings - The Globe and Mail
Intelligent Bio Solutions Expands Global Reach with Multilingual Digital Strategy - citybuzz -
INBS Expands Workforce Drug Testing with Successful Remote Opera - GuruFocus
Intelligent Bio Solutions Showcases Rapid, Non-Invasive Drug Tes - GuruFocus
Intelligent Bio Solutions Showcases Rapid, Non-Invasive Drug Testing Capabilities in Remote Queensland Workforce Deployment | INBS Stock News - GuruFocus
Intelligent Bio Solutions Showcases Rapid, Non-Invasive Drug Testing Capabilities in Remote Queensland Workforce Deployment - The Manila Times
Intelligent Bio Solutions Inc. Successfully Conducts High-Volume Workforce Drug Testing for Barcaldine Regional Council in Queensland, Australia - Nasdaq
Revolutionary 10-Minute Fingerprint Drug Test Transforms Workplace Screening: 160 Workers Tested Before Breakfast - Stock Titan
4 Top Cybersecurity Stocks to Buy in May - The Globe and Mail
Intelligent Bio Solutions (NASDAQ: INBS) Surpasses 450 Accounts as Fingerprint Drug Testing Expands Globally - The Globe and Mail
Intelligent Bio Solutions Expands Global Operations - TipRanks
Intelligent Bio Solutions (INBS) Achieves Significant Growth wit - GuruFocus
IBN Coverage: Intelligent Bio Solutions (NASDAQ: INBS) Surpasses 450 Accounts as Fingerprint Drug Testing Expands Globally - Yahoo Finance
Intelligent Bio Solutions (INBS) Achieves Significant Growth with New Accounts and Technology | INBS Stock News - GuruFocus
Intelligent Bio Solutions Accelerates Global Adoption of Fingerprint Drug Testing - The Manila Times
Intelligent Bio Solutions Inc. Reports Significant Growth Across Global Operations with Over 450 Active Accounts and Expansion into New Sectors - Nasdaq
0.54%
1.82%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):